MedOrion

AI-based Health Behavior Management Platform

Health Tech & Life Sciences
Active
Series A Tel Aviv-Yafo Founded 2017
Total raised
$8.8M
Last: Series A 2025-10
Stage
Series A
Founded
2017
Headcount
42
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

MedOrion enables health plans and risk-bearing providers to have a transformative influence on their members health through its Health Behavior Management (HBM) AI platform. MedOrions SaaS HBM solution brings an intelligent order to the complex and ever-changing landscape of health data, individual behavior, and external factors impacting membership, automatically creating positive, persuasive individualized communication while also helping to formulate more effective long-term strategies.

Funding history · 7 rounds · $8.8M total

2025-10
Series A Undisclosed
2025-05
SAFE Undisclosed
2024-02
Series A Undisclosed
2021-07
Series A $6.0M
2019-08
Seed $1.6M
2018-10
Seed $800K
2017-01
Pre-Seed $400K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was MedOrion founded and what is its primary focus?
MedOrion was founded in January 2017. It focuses on an AI-based Health Behavior Management Platform that enables health plans and risk-bearing providers to influence their members' health.
What is MedOrion's total funding to date and its current funding stage?
MedOrion has raised a total of $8.8 million. Its current funding stage is Series A.
Which investors participated in MedOrion's Seed rounds?
Impact First Investments, Naveh Shetrit, TAU Ventures, and iAngels participated in MedOrion's Seed funding rounds in October 2018 and August 2019.
When did MedOrion raise its first Series A round and who was the lead investor?
MedOrion raised a $6 million Series A round in July 2021, with 10D as the lead investor.
What new solution did MedOrion release in November 2024?
In November 2024, MedOrion released a new CAHPS solution, expanding its behavioral science software offerings.
When did MedOrion announce its first Health Behavior Management Software for U.S. based health plans?
MedOrion announced its first Health Behavior Management Software for U.S. based health plans in March 2022.
What recognition did MedOrion receive in February 2022?
In February 2022, MedOrion's Health Behavior Software won Pfizer's Vaccines Global Innovation Challenge.
How many employees does MedOrion currently have?
MedOrion currently has 42 employees.
What is the primary use case for MedOrion's HBM platform?
One primary use case for MedOrion's HBM platform is increasing cancer screening rates, specifically for Colorectal Cancer, among health plan members through AI-driven personalized interventions.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Engagement
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProvidersInsurance CompaniesLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

hospitalspatient-engagementpersonalizationdigital-healthcareadherenceartificial-intelligencepopulation-health-managementinsurance-companiesbehavior-analyticsdata-analyticsbig-datapreventionmachine-learningautomationmedicationdashboardpharma-companiessaasmhealthhealthcare-providers